![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Blumenberg, Viktoria 
ORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID: https://orcid.org/0000-0001-5487-5839; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL.
In: Blood Advances, Bd. 7, Nr. 22: S. 6844-6849
[PDF, 498kB]
ORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID: https://orcid.org/0000-0001-5487-5839; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL.
In: Blood Advances, Bd. 7, Nr. 22: S. 6844-6849
[PDF, 498kB]
Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
Marcinek, Anetta; Brauchle, Bettina; Rohrbacher, Lisa; Hänel, Gerulf; Philipp, Nora; Märkl, Florian; Strzalkowski, Thaddäus; Lacher, Sonja M.; Udiljak, Dragica; Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957; Theurich, Sebastian; Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673; Kischel, Roman; James, John R.; Bücklein, Veit L. und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
In: Cancer Immunology, Immunotherapy, Bd. 72, Nr. 7: S. 2499-2512
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-5139-4957; Theurich, Sebastian; Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673; Kischel, Roman; James, John R.; Bücklein, Veit L. und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
In: Cancer Immunology, Immunotherapy, Bd. 72, Nr. 7: S. 2499-2512
[PDF, 1MB]
Winkelmann, Michael; Bücklein, Veit L.; Blumenberg, Viktoria; Rejeski, Kai; Ruzicka, Michael; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion und Kunz, Wolfgang G.
(8. September 2022):
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment.
In: Frontiers in Oncology, Bd. 12
[PDF, 2MB]
Rohrbacher, Lisa; Brauchle, Bettina; Ogrinc Wagner, Ana; Bergwelt-Baildon, Michael von; Bücklein, Veit L. und Subklewe, Marion
(15. März 2021):
The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression.
In: Frontiers in Immunology, Bd. 12, 608625
[PDF, 1MB]
Karschnia, Philipp; Strübing, Felix; Teske, Nico; Blumenberg, Viktoria; Bücklein, Veit L.; Schmidt, Christian; Schöberl, Florian; Dimitriadis, Konstantinos; Forbrig, Robert; Stemmler, Hans-Joachim; Tonn, Jörg-Christian; Von Bergwelt-Baildon, Michael; Subklewe, Marion und Baumgarten, Louisa von
(2021):
Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells.
In: Hemasphere, Bd. 5, Nr. 3, e533
Lichtenegger, Felix S.; Schnorfeil, Frauke M.; Rothe, Maurine; Deiser, Katrin; Altmann, Torben; Bücklein, Veit L.; Köhnke, Thomas; Augsberger, Christian; Konstandin, Nikola P.; Spiekermann, Karsten; Moosmann, Andreas; Boehm, Stephan; Boxberg, Melanie; Heemskerk, Mirjam H. M.; Goerlich, Dennis; Wittmann, Georg; Wagner, Beate; Hiddemann, Wolfgang; Schendel, Dolores J.; Kvalheim, Gunnar; Bigalke, Iris und Subklewe, Marion
(2020):
Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial.
In: Clinical & Translational Immunology, Bd. 9, Nr. 3, e1117
[PDF, 1MB]
Köhnke, Thomas; Wittmann, Veronika K.; Bücklein, Veit L.; Lichtenegger, Felix; Pasalic, Zlatana; Hiddemann, Wolfgang; Spiekermann, Karsten und Subklewe, Marion
(2017):
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
In: British Journal of Haematology, Bd. 179, Nr. 3: S. 480-487